EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B

Sjoerd F Koopman iD, Tine M H J Goedhart, Laura H Bukkems iD, Trevor M Mulders, Frank W G Leebeek, Karin Fijnvandraat, Michiel Coppens, Mary Mathias, Peter W Collins, R Campbell Tait, Catherine N Bagot, Nicola Curry und 5 weitere

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.15881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Sjoerd F Koopman und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Centers, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Factor IX, Hemophilia B. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Recombinant factor IX Fc fusion protein (rFIX‐Fc) is an extended half‐life factor concentrate administered to haemophilia B patients. So far, a population pharmacokinetic (PK) model has only been published for patients aged ≥12 years. The aim was to externally evaluate the predictive performance of the published rFIX‐Fc population PK model for patients of all ages and develop a model that describes rFIX‐Fc PK using real‐world data.

Methods

We collected prospective and retrospective data from patients with haemophilia B treated with rFIX‐Fc and included in the OPTI‐CLOT TARGET study (NTR7523) or United Kindom (UK)‐EHL Outcomes Registry (NCT02938156). Predictive performance was assessed by comparing predicted with observed FIX activity levels. A new population PK model was constructed using nonlinear mixed‐effects modelling.

Results

Real‐world data were obtained from 37 patients (median age: 16 years, range 2–71) of whom 14 were aged

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor IXHemophilia BChildHumansChild, PreschoolAdolescentYoung AdultAdultMiddle AgedAgedRetrospective StudiesProspective StudiesRecombinant Fusion ProteinsHalf-Life

Stichwörter der Autor:innen

extended half-lifefactor IXhaemophilia Bpharmacokinetics

Substanzen

Factor IXRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Department of Pediatric Hematology and Oncology, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Pediatric Hematology, Amsterdam, The Netherlands.
  • Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Amsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis, Amsterdam, The Netherlands.

ORCID-Profile: Sjoerd F Koopman, Laura H Bukkems

Förderung

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Koopman, S. F., Goedhart, T. M. H. J., Bukkems, L. H., Mulders, T. M., Leebeek, F. W. G., Fijnvandraat, K., Coppens, M., Mathias, M., Collins, P. W., Tait, R. C., Bagot, C. N., Curry, N., Payne, J., Chowdary, P., Cnossen, M. H., Mathôt, R. A. A., & OPTI-CLOT study group and SYMPHONY consortium (2024). A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15881

Vancouver

Koopman SF, Goedhart TMHJ, Bukkems LH, Mulders TM, Leebeek FWG, Fijnvandraat K, et al. A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.15881

BibTeX
@article{Koopman2024,
  author = {Koopman, Sjoerd F and Goedhart, Tine M H J and Bukkems, Laura H and Mulders, Trevor M and Leebeek, Frank W G and Fijnvandraat, Karin and Coppens, Michiel and Mathias, Mary and Collins, Peter W and Tait, R Campbell and Bagot, Catherine N and Curry, Nicola and Payne, Jeanette and Chowdary, Pratima and Cnossen, Marjon H and Mathôt, Ron A A and OPTI-CLOT study group and SYMPHONY consortium, OPTI-CLOT study group and SYMPHONY consortium},
  title = {A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.15881}
}
Kostenlos starten →